Metabolic effects isradipine versus hydrochlorothiazide diabetes erratum Hypertension May antihypertensive drugs negative effects metabolic control diabetic patients Calcium antagonists antihypertensive treatment diabetics possible influence glucose tolerance insulin secretion insulin action unknown effect calcium antagonist isradipine glucose tolerance insulin secretion oral glucose tolerance test peripheral hepatic insulin action euglycemic clamp type II diabetic patients patients placebo isradipine weeks double-blind design second group diabetic patients thiazide diuretic hydrochlorothiazide protocol Systolic blood pressure isradipine hydrochlorothiazide placebo versus mm Hg versus blood glucose versus mg/dl glucose levels basal glucose-stimulated insulin levels hydrochlorothiazide placebo unchanged calcium antagonist treatment Basal hepatic glucose production peripheral insulin resistance hydrochlorothiazide placebo calcium antagonist therapy data calcium antagonist isradipine effect glucose tolerance insulin secretion insulin action type II diabetic patients useful drug antihypertensive treatment diabetes diuretic treatment metabolic control reduction insulin action type II mellitus 